Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Kiniksa Pharmaceuticals, Ltd.

KNSA

Valuace

Růst

Zdraví

Cena

$ 47.97

+1.49 (3.93%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total Revenues	677.6	677.6	423.2	270.3	220.2	38.5	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	307.4	307.4	60.9	56.5	47.0	9.1	0.0	0.0	0.0	0.0	0.0
Gross Profit	370.2	370.2	362.3	213.7	173.2	29.4	0.0	0.0	0.0	0.0	0.0

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	202.1	180.9	156.8	137.8	122.5	112.2	108.6	79.9	83.4	67.0
Cost of Revenues	91.1	83.6	71.0	61.7	66.2	49.4	42.5	31.5	26.8	26.4
Gross Profit	111.0	97.3	85.8	76.1	56.4	62.8	66.2	48.3	56.6	40.6

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
R&D Expenses	0.0	0.0	0.0	76.1	65.5	99.3	112.0	135.0	86.6	56.4	17.4
Selling General & Admin Expenses	0.0	0.0	0.0	129.4	98.0	85.9	45.3	35.0	21.6	9.0	6.6
Depreciation & Amortization	1.6	1.6	1.7	2.3	2.4	2.4	2.4	2.1	0.3	0.0	0.0
Total Operating Expenses	293.0	292.9	407.9	238.9	163.4	186.1	157.4	170.0	108.2	65.4	24.0
Operating Income	77.2	77.2	-45.6	-25.2	7.4	-156.6	-157.4	-170.0	-108.2	-65.4	-24.0

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	17.1
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	34.5
Depreciation & Amortization	0.5	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.2	1.0
Total Operating Expenses	91.3	73.2	65.6	62.9	75.7	72.5	66.3	64.9	56.6	51.6
Operating Income	19.8	24.0	20.2	13.3	-19.3	-9.7	-0.1	-16.5	0.1	-10.9

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Interest Income	5.4	0.0	9.5	8.5	1.3	0.1	1.1	6.0	4.7	0.5	0.1
Interest Expense	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0
Other Expense	11.6	11.6	9.5	8.5	3.7	0.1	1.1	6.0	4.7	0.5	0.1
IBT	88.9	88.9	-36.2	-16.7	11.0	-156.5	-156.2	-163.9	-103.4	-64.9	-23.9
Income Tax Expense	29.9	29.9	7.0	-30.7	-172.3	1.4	5.2	-2.0	-0.2	0.0	0.0
Net Income	59.0	59.0	-43.2	14.1	183.4	-157.9	-161.4	-161.9	-103.2	-64.9	-24.0

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	2.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.4	2.4
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0
Other Expense	3.5	3.1	2.7	2.3	2.3	2.5	2.4	2.3	2.4	2.4
IBT	23.3	27.2	22.9	15.6	-17.0	-7.2	2.3	-14.3	2.5	-8.5
Income Tax Expense	9.1	8.7	5.0	7.0	-8.1	5.5	6.2	3.4	-22.8	5.4
Net Income	14.2	18.4	17.8	8.5	-8.9	-12.7	-3.9	-17.7	25.2	-13.9

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
EPS	$0.00	$0.00	$0.00	$0.20	$2.64	$-2.30	$-2.61	$-2.99	$-3.49	$-2.00	$-0.74
EPS Diluted	$0.00	$0.00	$0.00	$0.20	$2.60	$-2.30	$-2.61	$-2.99	$-3.49	$-2.00	$-0.74
Shares Outstanding	74.2	74.2	71.4	70.1	69.4	68.6	61.8	54.0	29.5	32.5	32.5
Diluted Shares Outstanding	79.0	79.0	71.4	71.9	70.4	68.6	61.8	54.0	29.5	32.5	32.5

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.36	$-0.20
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.35	$-0.20
Shares Outstanding	74.2	73.6	73.4	72.6	72.3	71.7	71.0	70.6	70.4	70.2
Diluted Shares Outstanding	79.0	78.0	77.9	76.1	72.3	71.7	71.0	70.6	72.7	70.2

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash And Equivalents	99.3	183.6	108.0	122.7	122.5	114.0	46.9	307.3	45.6	56.0
Short Term Investments	119.5	60.0	98.4	67.9	59.7	209.4	186.5	235.3	0.0	0.0
Total Cash & ST Investments	218.8	243.6	206.4	190.6	182.2	323.5	233.4	307.3	45.6	56.0
Accounts Receivable	20.5	41.7	21.3	20.3	4.0	0.0	0.0	0.0	0.0	0.0
Inventory	34.9	26.4	31.1	21.6	3.7	0.0	0.0	0.0	0.0	0.0
Other Current Assets	27.0	20.1	17.5	10.5	6.6	9.6	8.2	6.4	1.4	0.3
Total Current Assets	301.0	331.8	276.3	243.1	196.4	333.2	241.6	313.8	47.1	56.3

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	174.9	192.0	157.1	183.6	97.4	99.3	141.1	108.0	117.8	112.6
Short Term Investments	177.2	115.7	111.2	60.0	126.4	119.5	72.5	98.4	83.3	72.4
Total Cash & ST Investments	352.1	307.8	268.3	243.6	223.8	218.8	213.6	206.4	201.1	185.0
Accounts Receivable	0.0	31.9	40.1	41.7	24.9	20.5	16.0	21.3	3.0	24.7
Inventory	0.0	48.2	22.1	26.4	28.7	34.9	27.3	31.1	25.6	24.0
Other Current Assets	123.4	32.4	25.4	20.1	34.0	27.0	13.8	17.5	26.4	12.4
Total Current Assets	475.5	420.3	355.9	331.8	311.3	301.0	270.6	276.3	256.1	185.0

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Property, Plant & Equipment	12.4	11.0	12.7	7.0	8.4	10.6	8.3	6.4	0.1	0.1
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	16.8	16.3	17.3	18.3	19.3	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	7.9	10.3	0.8	5.8	8.7	5.6	0.2	0.6	0.0	0.0
Total Long-Term Assets	241.4	248.8	250.0	216.6	36.4	16.2	12.9	8.2	0.4	0.1
Total Assets	542.4	580.6	526.3	459.7	232.8	349.5	254.5	322.0	47.5	56.5

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	0.0	11.4	11.1	11.0	11.7	12.4	13.0	12.7	13.6	14.3
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	15.5	15.8	16.0	16.3	16.5	16.8	17.0	17.3	17.5	17.8
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Long-Term Assets	221.3	8.2	8.2	10.3	7.9	7.9	4.1	0.8	2.3	2.4
Total Long-Term Assets	236.8	240.8	243.4	248.8	244.0	241.4	249.1	250.0	227.0	238.3
Total Assets	712.3	661.2	599.3	580.6	555.3	542.4	519.7	526.3	483.1	484.3

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Accounts Payable	7.4	2.0	8.2	7.9	1.9	0.5	5.7	10.9	1.2	0.2
Short-Term Debt	2.1	2.0	4.5	3.3	3.4	2.1	1.7	0.0	0.0	0.0
Other Current Liabilities	74.8	96.6	50.6	23.9	1.5	0.0	0.0	31.6	16.2	2.1
Current Liabilities	84.3	100.6	63.7	47.1	44.8	31.8	27.8	42.6	17.4	2.3

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.0	9.0	2.0	2.0	8.3	7.4	5.6	8.2	1.0	0.6
Short-Term Debt	2.7	2.5	2.3	2.0	2.0	2.1	2.3	4.5	4.6	4.5
Other Current Liabilities	120.9	74.5	93.0	96.6	85.6	74.8	56.1	50.6	45.3	37.7
Current Liabilities	123.6	117.8	97.3	100.6	96.0	84.3	64.2	63.7	53.5	47.5

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Long-Term Debt	9.3	7.9	10.0	2.6	2.7	4.9	1.0	0.0	0.0	0.0
Capital Leases	9.3	9.9	12.3	5.9	6.1	7.0	2.7	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0
Total Liabilities	107.3	142.1	87.5	63.5	47.8	37.5	29.1	42.7	137.2	82.2

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	7.0	7.2	7.6	7.9	8.6	9.3	9.9	10.0	10.7	11.3
Capital Leases	9.7	9.8	9.9	9.9	10.6	11.4	12.1	10.0	13.0	13.5
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	177.0	166.1	141.8	142.1	118.3	107.3	87.8	87.5	77.9	72.7

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-499.6	-521.1	-478.0	-492.0	-675.4	-517.5	-356.1	-194.2	-91.0	-26.1
Comprehensive Income	-0.1	-0.2	0.0	0.0	-0.1	0.0	0.0	0.0	-0.1	0.0
Total Common Equity	435.1	438.4	438.8	-492.0	-675.4	-517.5	-356.1	-194.2	-89.7	-25.7

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-476.3	-494.8	-512.6	-521.1	-512.3	-499.6	-495.7	-478.0	-503.2	-489.3
Comprehensive Income	-0.2	-0.1	-0.2	-0.2	0.0	-0.1	-0.1	0.0	0.0	0.0
Total Common Equity	535.4	495.0	457.5	438.4	437.0	435.1	431.9	438.8	-503.2	-489.3

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total Debt		11.4	9.9	12.3	5.9	6.1	7.0	2.7	0.0	0.0	0.0
Book Value		435.1	438.4	438.8	396.1	185.0	311.9	225.4	279.3	-89.7	-25.7

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		535.4	495.0	457.5	438.4	437.0	435.1	431.9	438.8	-503.2	-489.3

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-10.2	-43.2	-43.2	14.1	183.4	-157.9	-161.4	-161.9	-103.2	-64.9	-24.0
Depreciation & Amortization	1.7	1.7	1.7	2.3	2.4	2.4	2.4	2.1	0.3	0.0	0.0
Stock-Based Compensation	29.1	30.7	30.7	27.1	25.1	25.2	20.9	15.1	5.7	0.9	0.4
Change Working Capital	5.7	51.6	24.8	1.4	-22.6	0.7	-4.3	-17.0	18.3	13.9	1.8
Change In Accounts Receivable	4.2	26.1	-20.5	-1.0	-8.7	-3.9	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	6.7	-6.3	-6.3	0.3	6.0	1.4	-5.0	-4.7	8.8	1.0	0.1
Change In Inventories	-10.9	4.8	4.8	-9.5	-17.9	-3.7	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	24.8	-23.3	3.6	2.2	3.0	3.4	1.5	6.5	-1.1	0.0	0.0
Cash from Operations	30.5	0.0	0.0	13.3	5.8	-126.3	-136.5	-158.4	-81.0	-50.2	-21.9

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-88.0	18.4	17.8	8.5	-8.9	-12.7	-3.9	-17.7	25.2	-13.9
Depreciation & Amortization	0.3	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.2	0.6
Stock-Based Compensation	3.9	10.1	8.9	7.7	8.3	7.8	7.4	7.2	7.8	6.8
Change Working Capital	19.4	-1.0	-1.7	1.6	20.5	5.6	-9.9	8.6	-4.0	11.0
Change In Accounts Receivable	36.1	-19.8	8.2	1.7	-16.8	-4.4	-4.5	5.3	-18.2	21.6
Change In Accounts Payable	-10.6	-2.7	6.9	0.1	-6.3	0.9	1.7	-2.7	7.2	0.4
Change In Inventories	-13.5	6.8	-26.1	4.3	2.3	6.2	-7.6	3.8	-5.5	-1.6
Other Non-cash Items	119.9	1.5	0.0	1.1	1.6	0.3	0.6	1.1	0.7	2.1
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	17.0

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
Capital Expenditure	-0.2	-0.3	-0.3	-0.1	-0.1	-20.4	-0.3	-3.2	-5.3	-0.1
Acquisitions	27.1	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0
Investments	-239.4	-202.0	-202.0	-204.9	-135.9	-157.3	-430.2	-488.8	-402.0	0.0
Sales of Investment	191.1	239.9	239.9	175.5	127.8	306.3	407.1	541.2	168.1	0.0
Other Investing Activities	-48.3	0.0	0.0	0.0	0.1	-20.0	0.0	0.0	0.0	0.0
Cash from Investing	-48.4	0.0	0.0	-29.6	-8.1	128.6	-23.4	49.2	-239.2	-0.1

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	0.7	-0.7	-0.2	-0.1	-0.2	0.0	0.0	-0.1	-0.1	0.0
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	12.3
Investments	73.9	-146.2	-34.3	-95.5	-22.0	-54.5	-89.3	-36.3	-60.8	-53.1
Sales of Investment	81.2	84.1	30.6	44.0	87.5	48.1	42.4	61.9	46.0	40.8
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-14.8	-12.3
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-14.9	-12.3

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	-2.1	9.9	-2.4	6.3	-0.1	-0.9	4.3	2.7	0.0	0.0	0.0
Issuance of Common Stock	4.7	0.0	0.0	0.0	3.4	0.0	221.7	83.1	159.2	0.0	0.0
Repurchase of Common Stock	-3.1	-7.7	-5.0	-2.2	-0.9	5.9	6.6	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	2.1	0.0	0.0	3.7	0.0	0.0	-1.1	1.0	187.5	39.9	42.5
Cash from Financing	4.7	0.0	0.0	1.5	2.5	5.9	227.1	84.1	346.7	39.9	42.5

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	9.7	0.0	-0.2	0.1	-0.7	-0.8	-0.7	-0.1	-0.7	-0.6
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	-0.9	-4.4	-2.0	-0.4	-0.6	-2.7	-1.3	-0.4	-0.3	-1.1
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Net Change in Cash		-13.3	75.6	75.6	-14.8	0.2	8.2	67.1	-25.0	26.5	-10.4	20.6
Closing Cash Balance		99.3	183.6	183.6	108.0	122.7	122.5	114.2	47.1	72.2	45.7	56.1

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-9.3	-17.2	34.9	-26.4	86.2	-1.9	-41.8	33.1	-9.9	5.3
Closing Cash Balance		165.6	174.9	192.0	157.1	183.6	97.4	99.3	141.1	108.0	117.8

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Free Cash Flow		30.3	25.4	25.4	13.2	5.7	-146.7	-136.8	-161.6	-86.3	-50.3	-21.9
Real Free Cash Flow		1.2	-5.3	-5.3	-14.0	-19.4	-171.9	-157.7	-176.7	-92.0	-51.2	-22.2

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		53.3	33.0	27.9	22.2	18.6	-2.2	5.2	3.9	4.3	17.0
Real Free Cash Flow		49.3	22.9	19.0	14.5	10.3	-10.1	-2.2	-3.3	-3.5	10.2